v3.25.1
Notes Payable (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jan. 04, 2024
Oct. 04, 2023
Jul. 25, 2023
Dec. 31, 2022
Feb. 04, 2022
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Jun. 26, 2023
Debt Instrument [Line Items]                      
Accrued interest           $ 0   $ 0   $ 14,182  
Redemption premium related to convertible note         $ 600,000            
Payment of redemption premium               0 $ 120,000    
Payment of redemption premium in stock               0 120,000    
Accretion interest expense               0 180,000    
Redeemed cash               0 600,000    
Redeemed debentures               0 300,000    
Genefic Inc [Member]                      
Debt Instrument [Line Items]                      
Interest rate     20.00%                
Loans payable           1,713,034   $ 1,713,034      
Debt periodic payment   $ 800,000 $ 1,200,000                
Line of credit     $ 2,000,000                
Terms of loan     24 months                
Origination fee     $ 20,000                
Shares issued     500,000                
Amortization of debt discount     $ 189,971                
Genefic Specialty R X Inc [Member]                      
Debt Instrument [Line Items]                      
Revenue purchase $ 350,000                    
Revenue percentage 17.00%                    
Total revenue purchase $ 507,500                    
Underwriting fee 10,500                    
Origination fee $ 10,500                    
Loan description               On January 22, 2024, Genefic Specialty Rx, Inc. executed a loan and security agreement whereby Genefic Specialty Rx, Inc. can borrow 80% of the estimated accounts receivable at 2% interest per month for up to a maximum draw down of 1,250,000. The agreement includes a $5,000 expense deposit.      
Pacific Stem [Member] | E I D L Loan [Member]                      
Debt Instrument [Line Items]                      
Loans payable           149,900   $ 149,900   149,900  
I H G [Member] | E I D L Loan [Member]                      
Debt Instrument [Line Items]                      
Loans payable           141,228   141,228   147,807  
Related Entity 6 [Member]                      
Debt Instrument [Line Items]                      
Accrued interest           0   $ 0   11,144  
Interest rate               30.00%      
Related Entity 4 [Member]                      
Debt Instrument [Line Items]                      
Accrued interest           $ 0   $ 0   0  
Debt Instrument, Interest Rate Terms               3%, 8% and 10%      
C O V I D 19 Government Loan [Member]                      
Debt Instrument [Line Items]                      
Debt stated interest rate           2.50%   2.50%      
C O V I D 19 Government Loan [Member] | Likido [Member]                      
Debt Instrument [Line Items]                      
Loans payable           $ 27,321   $ 27,321   $ 36,938  
Watson [Member]                      
Debt Instrument [Line Items]                      
Debt stated interest rate           5.00%   5.00%   5.00%  
Loans payable           $ 96,436   $ 96,436   $ 320,709  
Maturity date               Apr. 29, 2025   Apr. 29, 2025  
Debt periodic payment               $ 2,656      
Balloon payment           $ 96,436   96,436      
Account receivable               $ 46,838      
Watson 1 [Member]                      
Debt Instrument [Line Items]                      
Debt stated interest rate           8.50%   8.50%   8.25%  
Loans payable                     $ 176,836
Maturity date               Jun. 26, 2024      
Ya I I P N Debentures [Member] | Securities Purchase Agreement [Member]                      
Debt Instrument [Line Items]                      
Debt stated interest rate         5.00%            
Debt face amount         $ 3,000,000            
Proceeds from convertible debt         $ 2,880,000            
Conversion price         $ 0.9151            
Warrants issued shares         983,499            
Debt Issuance Costs         $ 120,000            
Stock issued new, shares         192,000            
Stock issue new, value         $ 115,200            
Ya I I P N Debentures [Member] | Warrants [Member] | Securities Purchase Agreement [Member]                      
Debt Instrument [Line Items]                      
Debt Instrument, Unamortized Discount         1,427,495            
Ya I I P N Debentures [Member] | Convertible Notes [Member] | Securities Purchase Agreement [Member]                      
Debt Instrument [Line Items]                      
Accrued interest           $ 0 $ 4,965 $ 0 4,965    
Interest expense           0 13,226        
Amortization of debt discount           0 $ 406,932        
Debt Instrument, Unamortized Discount         $ 1,659,442            
Convertible Notes Payable           0   0   $ 0  
Notes Payable Related Parties [Member]                      
Debt Instrument [Line Items]                      
Accrued interest           $ 0   0   $ 14,182  
Interest expense               $ 220,496 $ 605,156    
Notes Payable Related Parties [Member] | Debt Dated Prior To 2022 [Member]                      
Debt Instrument [Line Items]                      
Debt stated interest rate       3.00%              
Debt maturity date - beginning range       Jun. 25, 2020              
Debt maturity dates - ending range       Dec. 30, 2022              
Notes Payable Related Parties [Member] | Notes Dated After 2022 [Member]                      
Debt Instrument [Line Items]                      
Debt stated interest rate       8.00%